Name | Title | Contact Details |
---|
Mrs. Dunster's (1996) Inc. is a Sussex, NB-based company in the Business Services sector.
Adventure Escapes Magazine is a Dallas, TX-based company in the Business Services sector.
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
Third Bridge is a leading independent financial research company that provides private equity firms, hedge funds and strategy consultants with the information they need to make informed decision about investment opportunities. Our vision for delivering deep insight and unbiased market intelligence has evolved into a business with a range of complementary services, seven offices across three continents and a global client base. Whether it is facilitating a private conversation with an industry veteran, moderating a dialogue between experts and investors, or extracting insights from within the supply chain of a poorly documented industry, we are on our clients` side, helping them to make informed investment decisions. Prior to December 2015, Third Bridge was known as Cognolink.
Promisant is a Atlanta, GA-based company in the Business Services sector.